Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
BMC Cancer
|
November 15, 2024
Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
Cassie Pan, Kevin Ng, Jenna Voutsinas, et al.
Cancer Immunology Research
|
January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I
Aude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2019
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
Shailender Bhatia, Natalie V Longino, Natalie J Miller, et al.
Journal of Palliative Medicine
|
December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors
Cameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.
Cancer Medicine
|
March 29, 2022
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients
Cameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, et al.
Cancer Reports (Hoboken, N.J.)
|
February 5, 2025
Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal Melanoma
Jamie S K Takayesu, Upendra Parvathaneni, George E Laramore, et al.
Cancer
|
May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
K Kian Ang, Amy Chen, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
Renato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Head & Neck
|
April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers
Cristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
Advances in Radiation Oncology
|
November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
BMC Cancer
|
November 15, 2024
Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
Cassie Pan, Kevin Ng, Jenna Voutsinas, et al.
Cancer Immunology Research
|
January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-I
Aude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2019
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma
Shailender Bhatia, Natalie V Longino, Natalie J Miller, et al.
Journal of Palliative Medicine
|
December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint Inhibitors
Cameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.
Cancer Medicine
|
March 29, 2022
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients
Cameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, et al.
Cancer Reports (Hoboken, N.J.)
|
February 5, 2025
Adjuvant Proton Beam Radiation Therapy for Sinonasal Mucosal Melanoma
Jamie S K Takayesu, Upendra Parvathaneni, George E Laramore, et al.
Cancer
|
May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
K Kian Ang, Amy Chen, Walter J Curran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial
Renato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Head & Neck
|
April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers
Cristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
Advances in Radiation Oncology
|
November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Page
of 9